Viewing Study NCT00003759


Ignite Creation Date: 2025-12-24 @ 2:47 PM
Ignite Modification Date: 2026-01-19 @ 9:10 PM
Study NCT ID: NCT00003759
Status: COMPLETED
Last Update Posted: 2013-01-31
First Post: 1999-11-01
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: AD 32 With or Without BCG After Surgery in Treating Patients With Newly Diagnosed or Recurrent Superficial Bladder Cancer
Sponsor: Anthra Pharmaceuticals
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Bladder Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None stage 0 bladder cancer View
None stage I bladder cancer View
None recurrent bladder cancer View